Joseph France

Stock Analyst at Cantor Fitzgerald

(2.65)
# 1,987
Out of 5,124 analysts
56
Total ratings
66.67%
Success rate
10.72%
Average return

Stocks Rated by Joseph France

Acadia Healthcare Company
Sep 14, 2023
Maintains: Neutral
Price Target: $83$85
Current: $14.19
Upside: +499.01%
HCA Healthcare
Apr 24, 2023
Maintains: Buy
Price Target: $285$320
Current: $466.86
Upside: -31.46%
Elevance Health
Apr 21, 2023
Maintains: Buy
Price Target: $565$550
Current: $350.55
Upside: +56.90%
UnitedHealth Group
Apr 17, 2023
Maintains: Buy
Price Target: $590$600
Current: $330.11
Upside: +81.76%
Cross Country Healthcare
Mar 10, 2023
Initiates: Buy
Price Target: $30
Current: $8.10
Upside: +270.37%
CVS Health
Jun 17, 2022
Initiates: Buy
Price Target: $120
Current: $79.36
Upside: +51.21%
Tenet Healthcare
Jun 17, 2022
Initiates: Buy
Price Target: $80
Current: $198.72
Upside: -59.74%
Universal Health Services
Jun 17, 2022
Initiates: Hold
Price Target: $115
Current: $218.02
Upside: -47.25%
The Cigna Group
Jun 17, 2022
Initiates: Hold
Price Target: $270
Current: $275.23
Upside: -1.90%
Molina Healthcare
Jun 17, 2022
Initiates: Hold
Price Target: $310
Current: $173.54
Upside: +78.63%
Initiates: Hold
Price Target: $5
Current: $3.12
Upside: +60.26%
Initiates: Buy
Price Target: $510
Current: $256.13
Upside: +99.12%
Initiates: Buy
Price Target: $100
Current: $41.15
Upside: +143.01%
Maintains: Overweight
Price Target: $42$50
Current: $174.13
Upside: -71.29%
Maintains: Neutral
Price Target: $103$107
Current: $78.09
Upside: +37.02%
Downgrades: Neutral
Price Target: $12$10
Current: $2.37
Upside: +321.94%
Initiates: Overweight
Price Target: $77
Current: $107.35
Upside: -28.27%
Maintains: Overweight
Price Target: $45$46
Current: $34.38
Upside: +33.80%
Maintains: Neutral
Price Target: $75$80
Current: $76.37
Upside: +4.75%
Initiates: Overweight
Price Target: $34
Current: $44.34
Upside: -23.32%
Maintains: Overweight
Price Target: $20$21
Current: $16.08
Upside: +30.60%
Initiates: Overweight
Price Target: $60
Current: $33.74
Upside: +77.83%
Initiates: Overweight
Price Target: $7
Current: $27.19
Upside: -74.26%